(Q61868419)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

title

Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

author name string

T J Powles

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

M Dowsett

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

G Hutchison

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

A M Brodie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

H T Ford

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

J C Gazet

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

R C Coombes

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

publication date

1 January 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

number of pages

3

1 reference

Cancer Chemotherapy and Pharmacology

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

page(s)

253-255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00570496

2 October 2019

exact match

0 references

cites work

Aminoglutethimide for the treatment of advanced postmenopausal breast cancer

1 reference

12 December 2020

4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer

1 reference

12 December 2020

High-dose oral medroxyprogesterone acetate in heavily pretreated patients with metastatic breast cancer

1 reference

12 December 2020

Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report

1 reference

12 December 2020

Improved sensitivity in the measurement of estrogen receptor in human breast cancer.

1 reference

12 December 2020

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

12 December 2020

Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00570496

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677299%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

1 reference